Qoraa: Janice Evans
Taariikhda Abuurista: 27 Julay 2021
Taariikhda Cusboonaysiinta: 16 Noofeembar 2024
Anonim
Bifidobacterium breve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic...
Dareemoleyad: Bifidobacterium breve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic...

Qanacsan

Bifidobacteria waa koox bakteeriya ah oo caadi ahaan ku nool mindhicirada. Waxay ku kori karaan jirka dibadiisa ka dibna afka ayaa looga qaadan karaa daawo ahaan.

Bifidobacteria waxaa badanaa loo isticmaalaa shuban-biyoodka, calool-fadhiga, cilladda xiidmaha ee loo yaqaanno xannuunka mindhicirka xanaaqa, si looga hortago hargabka caadiga ah ama ifilada, iyo xaalado kale oo badan, laakiin ma jiraan wax caddeyn cilmi ah oo wanaagsan oo lagu taageerayo inbadan oo ka mid ah adeegsigaas

Cudurka Coronavirus 2019 (COVID-19): Ma jirto caddeyn wanaagsan oo lagu taageerayo isticmaalka bifidobacteria ee loogu talagalay COVID-19. Raac xulashooyinka hab-nololeedka caafimaadka qaba iyo hababka kahortagga ee la xaqiijiyay.

Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran waxay qiimeysaa waxtarka ku saleysan caddeynta sayniska iyadoo loo eegayo cabirka soo socda: Wax ku ool ah, Suurta gal ah inuu wax ku ool yahay, suurtagal tahay wax ku ool ah, macquul ahaan waxtar la'aan, suurtagal ahaan waxtar la'aan, waxtar la'aan, iyo caddayn ku filan oo lagu qiimeeyo.

Qiimeynta waxtarka ee BIFIDOBACTERIA waa sida soo socota:

Suurtagal inay wax ku ool u tahay ...

  • Calool fadhiga. Baadhitaanada badankood waxay muujinayaan in qaadashada bifidobacteria ay kordhin karto dhaqdhaqaaqa caloosha illaa 1.5 saxaro ah usbuucii dadka calool fadhiga qaba. Laakiin dhammaan noocyada bifidobacteria uma muuqdaan inay shaqeeyaan.
  • Caabuq ku dhaca mareenka dheef-shiidka oo u horseedi kara nabarro (Helicobacter pylori ama H. ​​pylori). Qaadashada bifidobacteria oo lagu daray lactobacillus oo ay weheliso daaweynta caadiga ah ee H. pylori therapy ayaa laga yaabaa inay gacan ka geysato ka takhalusista infekshinka H. pylori qiyaastii laba jeer iyo sidoo kale qaadashada heerka caadiga ah ee H. pylori therapy. Waxay sidoo kale yareyn kartaa dhibaatooyinka soo raaca sida shubanka iyo dhadhanka xun ee ka yimaada daaweynta H. pylori.
  • Cilad muddo-dheer ah ee mindhicirada waaweyn ee sababa calool xanuun (cillad maskaxeed xanaaqsan ama IBS). Baadhitaanada badankood waxay muujinayaan in qaadashada bifidobacteria muddo 4-8 toddobaad ah ay yareyn karto astaamaha IBS sida calool xanuun, dibbiro, iyo dhibaato haysashada saxarada. Waxay sidoo kale yareyn kartaa astaamaha sida walaaca iyo niyadjabka dadka qaba IBS. Laakiin dhammaan noocyada bifidobacteria uma muuqdaan inay shaqeeyaan.
  • Dhibaato ka dib qalliinka qanjirada 'ulitis' (pouchitis). Qaadashada isku-darka bifidobacteria iyo lactobacillus, oo leh ama aan lahayn streptococcus, afka ayaa umuuqda inay kaa caawineyso kahortagga pouchitis qalliinka kadib qalliinka loo yaqaan 'ulcerative colitis'.
  • Caabuqa marinnada hawada. Cilmi baarista badankeedu waxay muujineysaa in isticmaalka antibiyootikada ay kujirto bifidobacteria ay kahortagto infekshinka hawo mareenka sida hargabka caadiga ah ee dadka kale ee caafimaadka qaba, oo ay kujiraan caruurta da'da iskuulka iyo ardayda dhigata kulleejada. Laakiin qaadashada bifidobacteria uma muuqato inay yareynayso halista infekshinka hawo-mareenka ee carruurta isbitaalka la dhigay iyo dhalinyarada ama dadka waaweyn ee daryeelka ku jira.
  • Shuban uu sababo rotavirus. Siinta bifidobacteria dhallaanka qaba shuban-biyoodka rotaviral-ka waxay gaabin kartaa muddada cudurka shubanku hal maalin.
  • Cudurka shubanka ee socotada. Qaadashada bifidobacteria waxay ka caawisaa ka hortagga shubanka safarka marka loo isticmaalo daawooyinka kale sida lactobacillus ama streptococcus.
  • Nooc ka mid ah cudurada mindhicirka oo barara (ulcerative colitis). Cilmi baaris ayaa muujineysa in qaadashada probiotics-ka ay ku jirto bifidobacteria oo ay weheliso lactobacillus iyo streptococcus ay gacan ka geysan karto kordhinta heerka cafiska iyadoo ku dhowaad 2-laab ay ku dhacayaan dadka qaba ulcerative colitis. Si kastaba ha noqotee, cilmi baarisyada badankood waxay muujinayaan in bifidobacteria uusan faa'iido u lahayn kahortagga soo noqoshada.

Suurtagal ma ahan waxtar ...

  • Hoos u dhaca xusuusta iyo xirfadaha fekerka ee sida caadiga ku dhaca da'da. Bifidobacteria uma muuqato inay horumarineyso fikirka iyo xirfadaha xusuusta ee dadka waaweyn ee leh hoos u dhac caadi ah xagga xirfadaha fikirka.
  • Infekshinka marinka caloosha iyo bakteeriyada loo yaqaan Clostridium wuya. Cilmi baarista badankeedu waxay muujineysaa in qaadashada bifidobacteria oo ay weheliso probiotics kale aysan ka hortageyn shubanka uu sababo infekshanka Clostridium.
  • Horumarka dhallaanka. Siinta caanobooraha ay ku jirto bifidobacteria oo lagu daray lactobacillus ma hagaajinayso koritaanka dhallaanka.
  • Cayilka. Baadhitaanada badankood waxay muujinayaan in qaadashada bifidobacteria ilaa 6 bilood aysan wanaajinayn miisaanka oo yaraada dadka miisaanka culus ama cayilan.
  • Caabuqa dhiigga (sepsis). Ku darista bifidobacteria caanaha carruurta ayaan ka hortegeynin sepsis-ka carruurta dhicis ah.

Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...

  • Shuban ku dhaca dadka qaata antibiyootikada (shuban-biyoodka la xiriira antibiyootigga). Cilmi baaris ayaa muujisay qaadashada bifidobacteria oo ay weheliso antibiyootigyada waxay yareyn kartaa fursadda shubanka qiyaastii 45%. Laakiin natiijooyinka is khilaafsan qaarkood ayaa jira. Waa suurtagal in bifidobacteria ay kahortagi karto shubanka ay keento antibiyootikada qaar laakiin kuwa kale. Sidoo kale, bifidobacteria ayaa laga yaabaa inuu sifiican u shaqeeyo marka loo isticmaalo isku dhafka qaarkood ee lactobacillus iyo streptococcus. Laakiin isku-darka oo dhan uma muuqdaan inay shaqeynayaan.
  • Waxqabadka Ciyaaraha. Daraasad hore waxay muujisay qaadashada bifidobacteria inay ka caawinayso ciyaartooyda tababaran inay orod aad u dheer isla waqtigaas qaataan.
  • Cambaarta (atopic dermatitis). Cilmi baarisyada qaarkood waxay muujinayaan in bifidobacterium la siiyo dhallaanka ay caawin karto TREAT canbaarta, laakiin natiijooyin is khilaafsan ayaa jira. Cilmi baaris kale waxay muujineysaa in la siiyo bifidobacteria oo lagu daray lactobacillus haweenka uurka leh 2dii bilood ee ugu dambeysay uurka, ka dibna la siiyo ilmaha dhallaanka labada bilood ee ugu horreysa dhalashadiisa, waxay ka caawin kartaa KA HORTAGA cambaarta. Laakiin natiijooyin is khilaafsan ayaa jira. Siinta bifidobacteria oo lagu daray lactobacillus oo kaliya dhallaanka halista ku jira 6-da bilood ee ugu horreysa nolosha kama hortegeyso cambaarta.
  • Cudurka Celiac. Cilmi-baarista hore waxay muujineysaa in qaadashada bifidobacteria iyada oo qayb ka ah cunno-ka-madax-bannaan aysan hagaajinaynin calaamadaha caloosha iyo xiidmaha marka la barbar dhigo cunnooyinka keli ah ee carruurta lagu arko cudurka baruurta.
  • Hoos u dhaca xusuusta iyo xirfadaha fakarka ee dadka waayeelka ah taas oo ka badan waxa caadiga u ah da'dooda. Cilmi-baarista qaar waxay muujineysaa in qaadashada bifidobacteria ay hagaajiso xusuusta dadka qaba hoos u dhaca xirfadaha fekerka, laakiin uma muuqato inay kaa caawinayso luqadda ama awoodda inaad fiiro gaar ah u yeelato.
  • Xusuusta ilkaha. Cilmibaaris hore waxay muujisay in cunitaanka caano fadhi la bifidobacteria muddo 2 toddobaad ah aysan yareynaynin iligga ilkaha ku yaal.
  • Shuban. Daraasad hore ayaa lagu ogaaday in ku darsiga bifidobacteria ee Saccharomyces boulardii inuu xiriir la leeyahay shubanka sii yaraanaya ee caruurta sida lama filaanka ah ugu dhaca shubanku.
  • Xasaasiyad ku leh manka geed kedar ee Jabbaan. Daraasadaha qaarkood waxay muujinayaan in qaadashada bifidobacteria inta lagu jiro xilliga manka ay yareyneyso astaamaha sanka iyo indhaha ee xasaasiyadda manka ee Japan. Laakiin natiijooyin is khilaafsan ayaa jira. Bifidobacteria uma muuqato inay yareyneyso hindhisada ama calaamadaha cunaha ee la xariira xasaasiyadda manka ee Japan.
  • Cudur xiidmaha oo halis ah oo ku dhaca dhallaanka dhiciska ah (necrotizing enterocolitis ama NEC). Cilmi baaris ayaa muujisay in siinta kaliya ee bifidobacteria dhallaanka ka horreeya aysan ka hortegeynin xaaladdan. Laakiin in la siiyo bifidobacteria lactobacillus waxay yeelan kartaa faa iido yar.
  • Xanuun daran oo ka dhasha shucaaca. Daraasad hore waxay muujisay in bifidobacteria-antibiyootig u adkaysta ay gacan ka geysan karto hagaajinta badbaadada muddada-gaaban ee daaweynta cudurka shucaaca. Marka lagu daro antibiyootikada, bifidobacteria waxay umuuqataa inay ka caawineyso ka hortagga bakteeriyada halista ah inay koraan oo ay keento infekshin daran.
  • Rheumatoid arthritis (RA).
  • Caabuqyada kalyaha, kaadi haysta, ama kaadi mareenka (infekshinka kaadi mareenka ama UTIs).
  • Gabow.
  • Xanuunka naasaha, oo laga yaabo inuu ku dhaco infekshin (mastitis).
  • Kansarka.
  • Cudurka laba-cirifoodka.
  • Cudurrada ku dhaca dadka lagu daweeyo daawooyinka kansarka.
  • Koritaanka ilmaha.
  • Kobaca iyo horumarka dhallaanka dhiciska ah.
  • Yaraynta ama xaddidan socodka qulqulka ee xiidmaha (cholestasis).
  • Sonkorowga.
  • Dulqaad la'aanta Laktose.
  • Dhibaatooyinka beerka.
  • Cudurka Lyme.
  • Qaamo-qashiir.
  • Murqo xanuun oo jimicsiga ka dhasha.
  • Heerarka sare ee kolestaroolka ama dufanka kale (lipids) ee dhiiga (hyperlipidemia).
  • Barar (barar) iyo dufanka beerka ku dhaca oo dadka cabba khamri yar ama aan khamri lahayn (nonalcohol steatohepatitis or NASH).
  • Barar (barar) iyo nabaro afka gudihiisa ah (xuubka afka laga qaato).
  • Shuban uu keeno shucaaca daaweynta.
  • Beddelidda bakteeriyada faa'iidada leh ee laga saaray shubanka.
  • Dhibaatooyinka caloosha.
  • Thrush.
  • Xaaladaha kale.
Caddeyn dheeri ah ayaa loobaahanyahay si loogu qiimeeyo bifidobacteria adeegsigaan.

Bakteeriyo badan iyo nooleyaal kale ayaa si caadi ah ugu dhex nool jirkeena. Bakteeriyada "Saaxiibtinimada leh" sida "bifidobacteria" waxay naga caawin kartaa inaan kala goyno cuntada, aan nuugno nafaqooyinka, iyo inaan la dagaallano noolaha "aan habboonayn" ee sababi kara cudurrada sida shubanka.

Markii afka lagaa qaado: Bifidobacteria waa KU SOO DHAWEYN SAFE dadka waaweyn ee caafimaadka qaba marka afka looga qaato si habboon. Dadka qaarkood, daaweynta bifidobacteria ayaa laga yaabaa inay xanuujiso caloosha iyo xiidmaha, taasoo keenta shuban, dibbiro iyo gaas.

Taxaddarrada gaarka ah & digniinta:

Uurka iyo nuujinta: Cillad gaar ah oo ah bifidobacteria, Bifidobacterium bifidum, waa BADBAADO KU SAABSAN marka afka si habboon loogu qaato 6 toddobaad inta aad uurka leedahay. Ma jiro macluumaad ku filan oo la isku halleyn karo oo ku saabsan badbaadada qaadashada noocyada kale ee cudurka bifidobacteria haddii aad uur leedahay ama aad naas nuujinayso. Joog dhinaca aaminka ah iskana ilaali isticmaalka.

Caruurta: Bifidobacteria waa KU SOO DHAWEYN SAFE loogu talagalay carruurta kuleylka leh marka afka si habboon loogu qaato. In kasta oo ay jireen xaalado cudurka infekshanka dhiigga ee bifidobacteria ee dhallaanka aadka u jiran, kiisaskaasi waa dhif.

Difaaca jirka oo daciifa: Waxaa jira xoogaa walaac ah in "probiotics" ay sifiican ugu koraan dadka qaba habka difaaca daciifka ah ayna sababaan cuduro. Inkasta oo tani aysan si gaar ah ugu dhicin bifidobacteria, waxaa jiray kiisas dhif ah oo ku lug leh noocyada kale ee probiotic sida Lactobacillus. Haddii aad leedahay tabar daciif ah (tusaale ahaan, waxaad qabtaa HIV / AIDS ama waxaad ku jirtaa daaweynta kansarka), ka hubi bixiyahaaga daryeelka caafimaadka kahor intaadan isticmaalin bifidobacteria.

Xayiraadda mindhicirada: Laba xaaladood oo infekshan dhiig ah ayaa loo soo sheegay dhallaanka la siiyay probiotics-ka 'bifidobacteria probiotics'. Labada xaaladoodba, dhallaanka waxaa lagu sameeyay qalliin caloosha ah. Waxaa loo maleynayaa in infekshannada dhiigga ay ka dhasheen xannibaadda mindhicirka ee ay sababeen qalliinnada caloosha, taas oo u oggolaatay bifidobacteria inuu u gudbo qulqulka dhiigga. Hal xaalad, qaadashada bifidobacteria ka dib xiidmaha xiidmaha oo la saxay ma aysan keenin infekshin kale oo dhiig ah. Sidaa darteed halista infekshinka dhiigga ayaan welwel ka qabin dhallaanka badankood ee qaata bifidobacteria. Laakiin bifidobacteria waa in loo isticmaalaa si taxaddar leh ama looga fogaadaa dhallaanka qaba caloosha ama xiidmaha xanibaada.

Dhexdhexaad
Ka taxaddar isku-dhafkan.
Dawooyinka antibiyootikada
Antibiyootikada waxaa loo isticmaalaa in lagu yareeyo bakteeriyada waxyeellada leh ee jirka ku jirta. Antibiyootikada ayaa sidoo kale yareyn karta bakteeriyada saaxiibtinimada leh ee jirka ku jirta. Bifidobacteria waa nooc bakteeriyo saaxiibtinimo leh. Qaadashada antibiyootikada oo ay weheliso bifidobacteria waxay yareyn kartaa waxtarka bifidobacteria. Si looga fogaado isdhexgalkaan, qaado alaabada bifidobacteria ugu yaraan labo saacadood kahor ama kadib antibiyootikada.
Ma jiraan is-dhexgal la yaqaan oo leh geedo iyo waxyaabo dheeri ah.
Ma jiraan wax la yaqaan oo la falgala cunnooyinka.
Qiyaasaha soo socda ayaa lagu bartay cilmi baarista sayniska:

DADKA WAAWEYN

Afka:
  • Calool fadhiga: 100 milyan ilaa 20 bilyan unugyada gumaysiga sameysma ee bifidobacteria ayaa la isticmaalay maalin kasta. Xaaladaha badankood, bifidobacteria waxaa la qaataa maalin kasta illaa toddobaadyo 1-4. Xaaladaha qaarkood 5-60 bilyan cutubyo gumeysi-sameys ah oo ah bifidobacteria oo lagu daray lactobacillus ayaa maalin walba la qaataa 1 toddobaad illaa 1 bil.
  • Cillada muddada-dheer ee mindhicirada waaweyn ee sababa calool xanuun (cillad-darrada mindhicirka xanaaqa ama IBS): Si loo hagaajiyo calaamadaha caloosha iyo xiidmaha, 100 milyan ilaa 1 bilyan unugyo gumeysi sameysma oo ah bifidobacteria ayaa maalin walba la isticmaali jiray 4-8 toddobaad. Sidoo kale, 5 bilyan cutubyo gumeysi sameysmo oo ah bifidobacteria oo lagu daray lactobacillus plus streptococcus ayaa la isticmaalay laba jeer maalintii muddo 4 toddobaad ah. Si loo wanaajiyo niyad-jabka iyo walwalka dadka qaba IBS, 10 bilyan cutubyo gumeysi-sameys ah oo ah bifidobacteria ayaa la isticmaalay hal mar maalin kasta illaa 6 toddobaad.
  • Infekshinka marin-haweedka: 3 bilyan cutubyo gumeysi sameys ah oo ah bifidobacteria ayaa maalin walba la isticmaali jiray muddo 6 toddobaad ah.
  • Dhibaato ka dib qalliinka qalliinka boogaha (pouchitis): qiyaas dhan ilaa 3 tiriliyan oo unug gumeysi-sameys ah oo ah bifodobacteria oo lagu daray lactobacillus plus streptococcus ayaa la siiyaa hal mar maalintii illaa 12 bilood.
  • Cudurka mareenka dheef-shiidka ee u horseedi kara nabarro (Helicobacter pylori ama H. ​​pylori): 5 bilyan cutubyo gumeysi sameys ah oo ah bifidobacteria oo lagu daray lactobacillus maalin kasta muddo 1 toddobaad ah inta lagu jiro daaweynta H. pylori oo lagu daray hal toddobaad intaas ka dib ayaa la isticmaalay.
  • Nooc ka mid ah cudurada mindhicirka bararka (ulcerative colitis): Kordhinta ka-dhaafista, 3 garaam oo u dhiganta 900 bilyan unugyada gumeysiga sameysma ee lactobacillus oo lagu daray bifidobacteria iyo streptococcus ayaa la isticmaali jiray hal mar ama laba jeer maalintii.
CARRUURTA

Afka:
  • Calool fadhiga: 1-100 bilyan cutubyo gumeysi-sameys ah oo ah bifidobacteria maalin kasta muddo 4 toddobaad ah ayaa loo isticmaalay carruurta da'doodu tahay 3-16 sano.
  • Cilad muddo-dheer ah ee mindhicirada waaweyn ee sababa calool xanuun (cillad maskaxeed xanaaqsan ama IBS): 10 bilyan cutubyo gumeysi sameys ah oo bifidobacteria ah maalin walba muddo 4 toddobaad ah ayaa la isticmaalay.
  • Infekshinka marin-haweedka: 2-10 bilyan cutubyo gumeysi sameys ah oo ka kooban isku-darka bifidobacteria oo lagu daray lactobacillus ayaa loo isticmaalay laba jeer maalintii carruurta da'doodu tahay 3-13 sano.
  • Shuban ka dhasha rotafayruusta: Bifidobacteria, oo ay weheliyaan ama la socdaan streptococcus, waxaa loo isticmaalay carruurta illaa 3 sano jir ah. Sidoo kale, bifidobacteria plus lactobacillus ayaa la isticmaali jiray laba jeer maalintii 3 maalmood.
  • Nooc ka mid ah cudurada mindhicirka bararka (ulcerative colitis): Ilaa 1.8 tirilyan oo unug gumeysi sameys ah oo ah bifidobacteria oo lagu daray lactobacillus plus streptococcus ayaa maalin walba loo isticmaali jiray illaa 1 sano carruurta 1-16 sano jir ah.
B. Bifidum, B. Breve, B. Infantis, B. lactis, B. Longum, Bifido, Bifido Bacterium Longum, Bifidobacterias, Bifidobactérie, Bifidobactéries, Bifidobacterium, Bifidobacterium adolescentis; Bifidobacterium animalis, Bifidobacterium bifidum; Bifidobacterium breve; Bifidobacterium infantis; Bifidobacterium lactis; Bifidobacterium longum, Bifidum, Bifidus, Bifidus Brevis, Bifidus Infantis, Bifidus Longum, Bifidobacteria Bifidus, Lactobacillus Bifidus, L. Bifidus, Probiotic, Probiotique.

Si aad wax badan uga ogaato sida maqaalkan loo qoray, fadlan eeg Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran habka.


  1. Athalye-Jape G, Minaee N, Nathan E, et al. Natiijooyinka ka hor xilliyada yar ee ka horreeya oo ku habboon ilmaha uurka leh ka dib markii Bifidobacterium breve M-16 V dheeri ah. J Matern Uurjiifka Dhallaanka Med. 2020; 33: 2209-2215. Eeg aragti
  2. Wu G, Chen X, Cui N, iyo al. Ka-hortagga ka-hortagga Bifidobacterium ee ku-darka cholestasis-ka carruurta ku jirta preterm neonates oo leh miisaan aad u hooseeya oo dhalasho ah. Tababbarka Gastroenterol Res. 2020; 2020: 4625315. Eeg aragti
  3. Xiao J, Katsumata N, Bernier F, iyo al. Nooca 'Probiotic bifidobacterium breve' ee lagu hagaajinayo howlaha garashada ee dadka waayeelka ah ee looga shakisan yahay cillad maskaxeed oo khafiif ah: Maxkamad la kantaroolay oo la kala soocay, laba-indhoole ah. J Alzheimers Dis. 2020; 77: 139-147. Eeg aragti
  4. Lin CL, Hsu YJ, Ho HH, iyo al. Bifidobacterium longum subsp. longum OLP-01 kaabis inta lagu gudajiro tababbarka orodka adkaysiga wuxuu hagaajiyaa waxqabadka jimicsiga orodyahanada dhexe iyo kuwa fog: Maxkamad laba-indho la 'oo kontaroolan. Nafaqooyinka. 2020; 12: 1972. Eeg aragti
  5. Lewis ED, Antony JM, Crowley DC, iyo al. Waxtarka Lactobacillus paracasei HA-196 iyo Bifidobacterium longum R0175 si loo yareeyo astaamaha cilladda mindhicirka xanaaqa (IBS): Daraasad la kala soocay, xakamaynta placebo. Nafaqooyinka. 2020; 12: 1159. Eeg aragti
  6. Michael DR, Jack AA, Masetti G, iyo al. Daraasad la kala soocay oo la kala soocay ayaa muujisay kaabista dadka waaweyn ee cayilan iyo kuwa cayilan ee leh lactobacilli iyo bifidobacteria waxay yareysaa miisaanka jirka waxayna hagaajineysaa fayoobaanta. Sci Rep. 2020; 10: 4183. Eeg aragti
  7. Czajeczny D, Kabzi & nacute; ska K, Wójciak RW. Kaaliyaha probiotic miyuu caawiyaa miisaanka oo yaraada? Daraasad la kala soocay, hal-indhoole ah, placebo-kontorool leh Bifidobacterium lactis BS01 iyo Lactobacillus acidophilus LA02 dheeri. Cun Culeyska Miisaanka. 2020. Eeg aragti.
  8. Jiao X, Fu MD, Wang YY, Xue J, Zhang Y. Bifidobacterium iyo Lactobacillus si looga hortago necrotizing enterocolitis ee dhallaanka uurka ku jira ee miisaankoodu aad u hooseeyo: dib u eegis nidaamsan iyo falanqayn meta. World J Pediatr. 2020; 16: 135-142. Eeg aragti
  9. Sadeghi-Bojd S, Naghshizadian R, Mazaheri M, Ghane Sharbaf F, Assadi F. Waxtarka prophytic prophylaxis ka dib markii ugu horeysay ee infakshanka kaadi mareenka ee qaaxada ee carruurta leh marinnada kaadi mareenka caadiga ah. J Cudurka Carruurta Dis Soc. 2020; 9: 305-310. Eeg aragti
  10. Butler CC, Lau M, Gillespie D, et al. Saamaynta isticmaalka antibiyootigga ee ku saabsan maamulka antibiyootikada ee ka dhexjirta dadka deggan guryaha daryeelka: Maxkamad caafimaad oo la kala soocay. JAMA. 2020; 324: 47-56. Eeg aragti
  11. Zhu XL, Tang XG, Qu F, Zheng Y, Zhang WH, Diao YQ. Bifidobacterium wuxuu ka faa'iideysan karaa ka hortagga necrotizing enterocolitis ee carruurta dhasha ah: Dib-u-eegis nidaamsan iyo falanqayn meta. Int J Surg. 2019; 61: 17-25. Eeg aragti
  12. Wang G, Feng D. Saamaynta daaweynta ee Saccharomyces boulardii oo lagu daray Bifidobacterium iyo howlaha difaaca jirka ee carruurta qaba shuban daran. Exp Ther Med. 2019; 18: 2653-2659. Eeg aragti
  13. Sharif A, Kashani HH, Nasri E, Soleimani Z, Sharif MR. Doorka Probiotics ee Daaweynta Cudurka Dabaysha: Waa Tijaabis Tijaabooyin Caafimaad oo Laba-Indho La 'ah. Probiotics-ka Antimicrob Proteins-ka. 2017; 9: 380-385. Eeg aragti
  14. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Probiotics miyuu nabdoon yahay? Bifidobacterium bakteeriya ilmo qaba wadno xanuun daran. Infez Med. 2019; 27: 175-178. Eeg aragti
  15. Manzhalii E, Virchenko O, Falalyeyeva T, Beregova T, Stremmel W. Waxtarka daaweynta ee u diyaargarowga probiotic ee steatohepatitis-ka aan khamriga lahayn: Maxkamad tijaabo ah. J Dig Dis. 2017; 18: 698-703. Eeg aragti
  16. Kobayashi Y, Kuhara T, Oki M, Xiao JZ. Saamaynta Bifidobacterium breve A1 oo ku saabsan waxqabadka garashada ee dadka waayeelka ah ee leh cabashooyinka xusuusta: tijaabin, laba-indhoole, tijaabinta xakamaynta xakamaynta. Microf Microbes. 2019; 10: 511-520. Eeg aragti
  17. Jiang C, Wang H, Xia C, iyo al. Tijaabin tijaabo ah, laba-indhoole ah, tijaabinta xakamaynta xakamaynta ah ee probiotics si loo yareeyo darnaanta murqaha afka ee ay keento chemoradiotherapy ee bukaanka qaba nasopharyngeal carcinoma. Kansarka. 2019; 125: 1081-1090. Eeg aragti
  18. Inoue T, Kobayashi Y, Mori N, iyo al. Saamaynta isku darka kaabista bifidobacteria iyo tababarka iska caabinta ee ku saabsan waxqabadka garashada, qaab dhismeedka jirka iyo caadooyinka caloosha ee maadooyinka waayeelka ah ee caafimaadka qaba. Microf Microbes. 2018; 9: 843-853. Eeg aragti
  19. Dimidi E, Zdanaviciene A, Christodoulides S, iyo al. Tijaabada caafimaad ee la kala soocay: Bifidobacterium lactis NCC2818 probiotic vs placebo, iyo saameynta waqtiga ku-socodka marinka, calaamadaha, iyo microbiology-ga caloosha ee joogtada ah. Aliment Pharmacol Ther. 2019; 49: 251-264. Eeg aragti
  20. Caglar E. Saamaynta Bifidobacterium bifidum oo ay ku jirto caano fadhi ah bakteeriyada ilkaha ee carruurta ku jirta. J Clin Pediatr Ilkaha. 2014; 38: 329-32. Eeg aragti
  21. Zhang J, Ma S, Wu S, Guo C, Long S, Tan H. Saamaynta Kordhinta Probiotic ee Haweenka Uurka leh Sonkorowga Uurka Mellitus: Dib-u-eegis nidaamsan iyo falanqaynta Meta-ka ee tijaabooyinka la xakameynayo ee aan kala sooca lahayn. J Sonkorowga Res. 2019; 2019: 5364730. Eeg aragti
  22. Slykerman RF, Kang J, Van Zyl N, iyo al. Saameynta kaabista hore ee probiotic ee garashada carruurnimada, dabeecadda iyo niyadda la kala soocay, tijaabada xakamaynta placebo. Acta Paediatr. 2018; 107: 2172-2178. Eeg aragti
  23. Schmidt RM, Pilmann Laursen R, Bruun S, iyo al. Probiotics-ka ilmanimada dambe waxay yareyneysaa dhacdooyinka cambaarta: Maxkamad la kantaroolay oo la kala soocay. Immunol-ka Xasaasiyadda Carruurta. 2019; 30: 335-340. Eeg aragti
  24. Linn YH, Thu KK, Guul NHH. Saameynta Probiotics ee Kahortagga Shuban-biyoodka Ba'an ee Bukaanka Kansarka Afka ilmo-galeenka: Daraasad Lagu Xakameynayo Meelo-Laba-indhood oo Kala-duwan. Probiotics-ka Antimicrob Proteins-ka. 2019; 11: 638-647. Eeg aragti
  25. Callaway LK, McIntyre HD, Barrett HL, iyo al. Probiotics loogu talagalay Kahortaga Sonkorowga Uurka Mellitus ee Dumarka Cayilan iyo Cayilan: Natiijooyinka laga helay SPRING Laba-indho indho-indheyn la tijaabiyey oo tijaabo ah. Daryeelka Sonkorowga. 2019; 42: 364-371. Eeg aragti
  26. Staudacher HM, Lomer MCE, Farquharson FM, et al. Cunto yari kujirta FODMAPs waxay yareeysaa astaamaha bukaanjiifka leh Cudurka Mindhicirka Xanaaqa iyo Probiotic Soo Celiya Noocyada Bifidobacterium: Maxkamad La Xakameeyay Oo La Kala Saaray. Gastroenterology. 2017; 153: 936-947. Eeg aragti
  27. Matsuoka K, Uemura Y, Kanai T, iyo al. Wax ku oolnimada Bifidobacterium breve Milk si loo ilaaliyo ka-reebista Cudurka 'Ulcer'. Dig Dis Sci. 2018; 63: 1910-1919. Eeg aragti
  28. Liu J, Huang XE. Waxtarka kiniiniyada bakteeriyada la adeegsan karo ee loo yaqaan 'Bifidobacterium tetragenous viable' ee loogu talagalay bukaannada kansarka qaba calool istaagga shaqeynaya. Aasiya Pac J Kansarka Prev. 2014; 15: 10241-4. Eeg aragti
  29. Lau AS, Yanagisawa N, Hor YY, et al. Bifidobacterium longum BB536 wuxuu yareeyay cudurrada neef mareenka sare iyo qaababka loo yaqaan 'microbiota gut' ee carruurta Malaysia ee iskuulka ka hor. Microf Microbes. 2018; 9: 61-70. Eeg aragti
  30. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Saamaynta 28-maalmood Bifidobacterium animalis subsp. lactis HN019 oo lagu daro dheellitirka waqtiga gumaarka iyo astaamaha caloosha ee dadka qaangaarka ah ee calool fadhiga shaqeynaya: Laba-indhoole, kala-soocid, xakameyn placebo, iyo tijaabooyin kala duwan. Gut Microbes. 2018; 9: 236-251. Eeg aragti
  31. Guardamagna O, Amaretti A, Puddu PE, et al. Kaabista Bifidobacteria: saameyn ku yeelashada astaamaha dhiigga 'plasma lipid' ee carruurta dyslipidemic. Nafaqada. 2014; 30 (7-8): 831-6. Eeg aragti
  32. Badehnoosh B, Karamali M, Zarrati M, iyo al. Saameynta ka-hortagga probiotic ee biomarkers-ka ee caabuqa, cadaadiska oksidheerka iyo natiijooyinka uurka ee sonkorowga uurka. J Matern Uurjiifka Dhallaanka Med. 2018 Meeyo; 31: 1128-1136. Eeg aragti
  33. Dickerson F, Adamos M, Katsafanas E, iyo al. Cudurka noole ee probiotic-ka ee looga hortago dib-u-kicinta bukaanka qaba miyir daran: Maxkamad la kantaroolay oo la kala soocay. Cudurka laba-cirifoodka 2018 Apr 25. Eeg aragti aan la taaban karin.
  34. Pinto GS, Cenci MS, Azevedo MS, Epifanio M, Jones MH. Saamaynta yogurt ay ku jirto Bifidobacterium animalis subsp. lactis DN-173010 probiotic oo ku saabsan huurada ilkaha iyo candhuufta bukaanka lafa-beelka. Caries Res. 2014; 48: 63-8. Eeg aragti
  35. Zamani B, Golkar HR, Farshbaf S, iyo al. Jawaabta bukaan socodka iyo dheef-shiid kiimikaadka ee ka-hortagga probiotic ee bukaannada qaba xanuunka 'rheumatoid arthritis: a randomized, double-blind, trial placebo-dependent. Int J Rheum Dis 2016; 19: 869-79. Eeg aragti
  36. Pinto-Sanchez MI, Hall GB, Ghajar K, iyo al. Probiotic Bifidobacterium longum NCC3001 wuxuu yareeyaa dhibcaha niyadjabka wuxuuna beddelaa dhaqdhaqaaqa maskaxda: daraasad tijaabo ah oo lagu sameeyo bukaannada qaba cilladda mindhicirka xanaaqa. Gastroenterology 2017; 153: 448-459.e8. Eeg aragti
  37. Karamali M, Dadkhah F, Sadrkhanlou M, iyo al. Saameynta ka-hortagga probiotic ee ku saabsan xakamaynta glycemic iyo astaamaha dufanka leh ee sonkorowga uurka: mid la kala soocay, indho-indhoole, tijaabo xakamaynta xakamaynta. Sonkorowga Metab 2016; 42: 234-41. Eeg aragti
  38. Jäger R, Purpura M, Stone JD, iyo al. Probiotic Streptococcus thermophilus FP4 iyo Bifidobacterium breve BR03 waxay xoojineysaa waxqabadka iyo hoos udhaca dhaqdhaqaaqa dhaqdhaqaaqa ka dib jimicsiga dhaawaca muruqyada. Nafaqooyinka 2016; 8. badan: E642. Eeg aragti
  39. Whorwell PJ, Altringer L, Morel J, iyo al. Wax ku oolnimada xannibaadaha loo yaqaan 'probiotic Bifidobacterium infantis 35624 ee haweenka qaba cilladda mindhicirka xanaaqsan. Am J Gastroenterol. 2006 Jul; 101: 1581-90. Eeg aragti
  40. Lau CS, Chamberlain RS. Probiotics-ku wuxuu waxtar u leeyahay ka hortagga shuban-biyoodka la xiriira Clostridium: dib-u-eegis nidaamsan iyo falanqayn metaleed. Int J Gen Med. 2016; 9: 27-37. Eeg aragti
  41. Stenman LK, Lehtinen MJ, Meland N, iyo al. Probiotic oo leh ama aan lahayn Fiber wuxuu xakameynayaa jirka dufanka jirka, oo ku xiran Serum Zonulin, oo ku jira Culeyska Dadka Waaweyn iyo Cayilka-Maxkamadeynta La Xakameeyay. EBioMedicine 2016; 13: 190-200. Eeg aragti
  42. Sato S, Uchida T, Kuwana S, iyo al. Bacteremia oo ay sababtay Bifidobacterium breve ee dhalaanka cusub ee leh 'cloacal exstrophy'. Pediatr Int. 2016; 58: 1226-8. Eeg aragti
  43. Jayasimhan S, Yap NY, Roest Y, Rajandram R, Chin KF. Wax ku oolnimada diyaarinta unugyada microbial ee lagu hagaajinayo calool istaagga daba dheeraaday: kala sooc la'aan, laba-indhoole, tijaabo xakamaynta placebo. Clin Nutr 2013; 32: 928-34. Eeg aragti
  44. Han K, Wang J, Seo JG, Kim H. Waxtarka probiotics-ka laba-daboolan ee loogu talagalay cilladda mindhicirka xanaaqa: tijaabin laba-indho-indhoole ah oo la kala sooco. J Gastroenterol. 2017; 52: 432-443. Eeg aragti
  45. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. Noocyo badan oo noocyada probiotics ah ayaa u muuqda kuwa ugu waxtarka badan ee ka hortagga necrotizing enterocolitis iyo dhimashada: Falanqeyn metaed oo la cusbooneysiiyay. QAADO Mid. 2017; 12: e0171579. Eeg aragti
  46. Bastürk A, Artan R, Yilmaz A. Wax ku oolnimada synbiotic, probiotic, iyo daaweynta prebiotic ee xannuunka mindhicirka xannuun ee carruurta: Maxkamad la kantaroolay oo la kala soocay. Turk J Gastroenterol 2016; 27: 439-43. Eeg aragti
  47. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics ee Ka Hortagga Shubanka Antibiyootikada-La Xiriira Bukaan-socodka Bukaannada-Dib-u-eegis Nidaam iyo Meta-Analysis. Antibiyootikada (Basel). 2017; 6. Eeg aragti
  48. Al Faleh K, Anabrees J. Probiotics ee ka hortagga necrotizing enterocolitis ee dhallaanka uurka ku jira. Macluumaadka Cochrane Syst Rev. 2014;: CD005496. Eeg aragti
  49. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. Saamaynta probiotics ee ku saabsan calool istaagga shaqada ee dadka qaangaarka ah: dib u eegis nidaamsan iyo falanqayn meta ah ee tijaabooyinka la xakameeyey. Am J Clin Nutr. 2014; 100: 1075-84. Eeg aragti
  50. Wildt S, Nordgaard I, Hansen U, Brockmann E, Rumessen JJ. Maxkamad xakameyn ku-meel-gaar ah oo laba-indhoole ah oo la kala soocay Lactobacillus acidophilus La-5 iyo Bifidobacterium animalis subsp. lactis BB-12 oo loogu talagalay dayactirka ka-soo-baxa qolofta nabarrada. J Crohns Colitis 2011; 5: 115-21. Eeg aragti
  51. Shen J, Zuo ZX, Mao AP. Saamaynta probiotics ee ku saabsan soo-kicinta iyo ilaalinta daaweynta ee ulcerative colitis, cudurka Crohn, iyo pouchitis: falanqaynta maadada ee tijaabooyinka la xakameeyey. Caloosha Caloosha Inflamm. 2014; 20: 21-35. Eeg aragti
  52. Park MS, Kwon B, Ku S, Ji GE4. Waxtarka Bifidobacterium longum BORI iyo Lactobacillus acidophilus AD031 Daaweynta Probiotic ee Dhallaanka qaba Cudurka Rotavirus. Nafaqooyinka. 2017; 9. pii: E887. Eeg aragti
  53. Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R. Saamaynta caano probiotic halsano leh oo ku saabsan astaamaha iyo dhirta xiidmaha mindhicirka ee bukaanka qaba cilladda mindhicirka xanaaqa: tijaabin, tijaabinta xakamaynta xakamaynta. Scand J Gastroenterol 2011; 46: 663-72. Eeg aragti
  54. Simrén M, Ohman L, Olsson J, iyo al. Tijaabinta bukaan socod eegtada: saameynta caano qallalan oo ay ku jiraan seddex bakteeriyada probiotic ee bukaanka qaba cilladda mindhicirka xanaaqsan - daraasad la kala soocay, laba-indhoole, xakameyn ah. Aliment Pharmacol Ther 2010; 31: 218-27. Eeg aragti
  55. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Daawada loo adeegsado kahortaga cudurka shuban biyoodka ee la xiriira antibiyootikada. Macluumaadka Cochrane Syst Rev. 2015;: CD004827. Eeg aragti
  56. O’Callaghan A, van Sinderen D. Bifidobacteria iyo Doorkooda Xubinnimada Human Gut Microbiota. Microbiol-ka hore. 2016 Juun 15; 7: 925. Eeg aragti
  57. Olivares M, Castillejo G, Varea V, Sanz Y.Laba-indhoole, la kala soocay, tijaabinta ciribtirka xakamaynta placebo si loo qiimeeyo saameynta Bifidobacterium longum CECT 7347 ee carruurta leh cudurka baruurta ee dhowaan la soo ogaaday. Br J Nutr. 2014 Jul 14; 112: 30-40. Eeg aragti
  58. Hojsak I, Tokic Pivac V, Mocic Pavic A, Pasini AM, Kolacek S. Bifidobacterium animalis subsp. lactis wuxuu ku guuldareystaa inuu ka hortago infekshannada caamka ah ee carruurta isbitaalka la dhigo: kala-sooc, indho-indhoole, daraasad lagu xakameynayo placebo Am J Clin Nutr. 2015 Mar; 101: 680-4. Eeg aragti
  59. Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Müller-Lissner S, Morberg CM. Saamaynta dhibaatada probiotic Bifidobacterium animalis subsp. lactis, BB-12®, oo ku saabsan inta jeer ee la saxaroodo maadooyinka caafimaadka qaba oo leh saxaro soo noqnoqota iyo raaxo daro caloosha ah: oo la kala sooco, laba-indhoole ah, xakamaynta placebo, tijaabo kooxeed isku mid ah. Br J Nutr. 2015 Nofeembar 28; 114: 1638-46. Eeg aragti
  60. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR; Probiotics ee Dhallaanka Uurka ah waxay Daraasad ku Sameeyaan Kooxda Wada Shaqeynta. Bifidobacterium breve BBG-001 ee dhallaanka aad uurka ku jira: marxalad 3 la xakameeyey oo la kala soocay. Lancet. 2016 Febraayo 13; 387: 649-60. Eeg aragti
  61. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, Mack D. Lactobacilli iyo bifidobacteria ee kahortaga shuban-biyoodka la xiriira iyo shuban biyoodka 'Clostridium' bukaan jiifka (PLACIDE): oo la kala soocay, indhoole laba indhoole ah, xakamaynta placebo, tijaabooyin badan. Lancet. 2013 Oktoobar 12; 382: 1249-57. Eeg aragti
  62. Roberfroid MB. Daaweynta prebiotics iyo probiotics: waa cunooyin shaqeynaya? Am J Clin Nutr. 2000; 71 (Qalabka 6): 1682S-7S; dood 1688S-90S. Eeg aragti
  63. Wang YH, Huang Y. Saamaynta Lactobacillus acidophilus iyo Bifidobacterium bifidum ku-dallaca daaweynta seddex-geesoodka ah ee caadiga ah ee cirib-tirka Helicobacter pylori iyo isbeddelada firfircoon ee dhirta xiidmaha. World J Microbiol Biotechnol. 2014; 30: 847-53. Eeg aragti
  64. Wang ZH, Gao QY, Fang JY. Falanqaynta Meta ee waxtarka iyo badbaadada Lactobacillus-ka kooban iyo Bifidobacterium-ku jira diyaarinta xarunta probiotic ee daaweynta ciribtirka Helicobacter pylori. J Clin Gastroenterol. 2013; 47: 25-32. Eeg aragti
  65. Videlock EJ, Cremonini F. Meta-analysis: probiotics ee shuban-biyoodka la xiriira antibiyootikada. Aliment Pharmacol Ther. 2012; 35: 1355-69. Eeg aragti
  66. Tomasz B, Zoran S, Jaroslaw W, Ryszard M, Marcin G, Robert B, Piotr K, Lukasz K, Jacek P, Piotr G, Przemyslaw P, Michal D. Isticmaalka mudada dheer ee probiotics-ka Lactobacillus iyo Bifidobacterium waxay leeyihiin saameyn kahortag ah dhacdooyinka iyo darnaanta pouchitis: daraasad la saadaalinayo oo la kala sooco. Biomed Res Int. 2014; 2014: 208064. Eeg aragti
  67. Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M, Minakari M, Shavakhi S, Gholamrezaei A. Saamaynta isku-darka daawada 'multistrain probiotic' ee ku saabsan bismuth-ku-daweynta afar-laba-cirifoodka ee loo yaqaan 'Helicobacter pylori infection': saddex-meelood meel xakamaynta xakamaynta -dhimasho daraasad. Helicobacter. 2013; 18: 280-4. Eeg aragti
  68. Rerksuppaphol S, Rerksuppaphol L. Tijaabinta tijaabada ah ee kontoroolka ah ee probiotics si loo yareeyo hargabka caadiga ah ee ardayda dugsiga. Pediatr Int. 2012; 54: 682-7. Eeg aragti
  69. Rautava S, Kainonen E, Salminen S, Isolauri E. Kaabista probiotic ee hooyada inta lagu jiro uurka iyo naas nuujinta waxay yareynaysaa halista canbaarta ee ilmaha. J Xasaasiyadda Clin Immunol. 2012; 130: 1355-60. Eeg aragti
  70. Langkamp-Henken B, Rowe CC, Ford AL, Christman MC, Nieves C Jr, Khouri L, Specht GJ, Girard SA, Spaiser SJ, Dahl WJ. Bifidobacterium bifidum R0071 waxay keentaa saami aad u badan oo maalmo caafimaad leh iyo boqolkiiba hoose ee ardayda tacliinta ku nuuxnuuxsatay ee ka warbixinaya maalin qabow / ifilo: daraasad la kala soocay, indhoole laba-indho-indheyn Br J Nutr. 2015 14; 113: 426-34. Eeg aragti
  71. Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, Peterson C, Morris J, Chaloner C, Murray CS, Woodcock A. Daaweynta iyo saameynta kahortaga labaad ee probiotics-ka Lactobacillus paracasei ama Bifidobacterium lactis on canbaarta hore ee ilmaha. : tijaabin kontorool ah oo la kala soocay oo lala socdo ilaa da'da 3 sano. Clin Xasaasiyadda 2012; 42: 112-22. Eeg aragti
  72. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, Gallardo-Sarmiento RB, García-Pérez CS, Montaño-Rodríguez R, Echániz-Aviles MO. Laba-indhoole, tijaabin caafimaad oo la kala soocay si loo qiimeeyo waxtarka probiotics-ka ee dhalaanka dhasha ah oo miisaankiisu ka yar yahay 1500 g ka hortagga necrotising enterocolitis. Arch Dis Ilmaha Uurka Leh Ed 2013; 98: F5-9. Eeg aragti
  73. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Daaweynta muddada-dheer ee loo yaqaan 'probiotics' ee bukaannada daryeelka aasaasiga ah ee leh cilladda mindhicirka oo xanaaq badan - oo la kala sooco, laba-indhoole, tijaabo xakameyn ah. Scand J Gastroenterol 2013; 48: 1127-35. Eeg aragti
  74. Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, Plummer SF, Wang D, Morgan G. Probiotics ee ka hortagga cambaarta: maxkamad la kantaroolay. Arch Dis Cunug 2014; 99: 1014-9. Eeg aragti
  75. Das RR Singh M, Shafiq N. Probiotics ee Daaweynta Rhinitis Xasaasiyadeed. Joornaalka Ururka Xasaasiyadda Adduunka 2010; 3: 239-244.
  76. Seki M, Igarashi T Fukuda Y Simamura S Kaswashima T Ogasa K. Saamaynta Bifidobacterium caano dhaqan ku leh "joogtaynta" koox da 'weyn. Nutr Cuntada 1978; 31: 379-387.
  77. Kageyama T, Nakano Y Tomoda T. Daraasad isbarbardhig ah oo ku saabsan Maamulka afka ee Qaar ka mid ah Diyaargarowga Bifidobacterium. Daawada iyo Biology (Japan) 1987; 115: 65-68.
  78. Kageyama T, Tomoda T Nakano Y. Saamaynta Maamulka Bifidobacterium ee Bukaannada qaba Leukemia. Bifidobacteria Microflora. 1984; 3: 29-33.
  79. Ballongue J, Grill J Baratte-Euloge P. Action sur la flore intestinale de laits fermentés au Bifidobacterium. Awood 1993; 73: 249-256.
  80. Ogata T, Kingaku M Yaeshima T Teraguchi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Lino H. Saamaynta maamulka Bifidobacterium longum BB536 yogurt ee ku saabsan deegaanka xiidmaha ee dadka waaweyn ee caafimaadka qaba. Microb Ecol Health Dis 1999; 11: 41-46.
  81. Tomoda T, Nakano Y Kageyama T. Kala duwanaanshaha kooxaha yar yar ee Flora mindhicirka joogtada ah inta lagu jiro Maamulka Anticancer ama Dawooyinka Immunosuppressive. Daawada iyo Biology (Japan) 1981; 103: 45-49.
  82. Tomoda T, Nakano Y Kageyama T. Xiidmaha Candida Baadhitaanka iyo Cudurka Candida ee Bukaannada qaba Leukemia: Saamaynta Maamulka Bifidobacterium. Bifidobacteria Microflora 1988; 7: 71-74.
  83. Araya-Kojima Tomoko, Yaeshima Tomoko Ishibashi Norio Shimamura Seiichi Hayasawa Hirotoshi. Saamaynta Xakamaynta ee Bifidobacterium longum BB536 oo ku jirta Bakteeriyada Xiidmaha Waxyeellada leh. Bifidobacteria Microflora 1995; 14: 59-66.
  84. Namba K, Yaeshima T Ishibashi N Hayasawa H iyo Yamazaki Shoji. Saamaynta Xannibaadda ee Bifidobacterium longum on Enterohemorrhagic Escherichia coli O157: H7. Bioscience Microflora 2003; 22: 85-91.
  85. Igarashi M, Iiyama Y Kato R Tomita M Asami N Ezawa I. Saamaynta Bifidobacterium longum iyo lactulose oo ku saabsan xoogga lafaha ee heerarka moodeelka 'ostearporosis ovariectomized'. Bifidus 1994; 7: 139-147.
  86. Yaeshima T, Takahashi S Ota S Nakagawa K Ishibashi N Hiramatsu A Ohashi T Hayasawa H Iino H. Saamaynta yogurt macaan oo ay kujirto Bifidobacterium longum BB536 oo ku saabsan saxarada soo noqnoqota iyo sifooyinka saxa ee dadka waaweyn ee caafimaadka qaba: Isbarbar dhigga yogurt heerka caadiga ah. Kenko Eiyo Shokuhin Kenkyu 1998; 1 (3/4): 29-34.
  87. Yaeshima T, Takahashi S Matsumoto N Ishibashi N Hayasawa H Lino H. Saamaynta yogurt ay kujirto Bifidobacterium longum BB536 oo ku saabsan deegaanka mindhicirka, astaamaha saxarada iyo saxarada soo noqnoqota: Isbarbar dhigga yogurt-ka caadiga ah. Biosci Microflora 1997; 16: 73-77.
  88. Xiao J, Kondol S Odamaki T Miyaji K Yaeshima T Iwatsuki K Togashi H Benno Y. Saamaynta yogurt ay kujirto Bifidobacterium longum BB 536 oo ku saabsan saxaarada inta badan iyo sifooyinka saxa ee dadka waaweyn ee caafimaadka qaba: Iskutallaab laba-indhoole ah oo dul maray daraasadda. Joornaalka Jabaan ee Bakteeriyada Acid Bakteeriyada 2007; 18: 31-36.
  89. Yaeshima T, Takahashi S Ogura A Konno T Iwatsuki K Ishibashi N Hayasawa H. Saamaynta Caanaha aan-khamiirka lahayn ee ka kooban Bifidobacterium longum BB536 ee ku saabsan Soo noqnoqoshada Saxaaraha iyo Astaamaha Caadiga ah ee Dadka Waaweyn ee Caafimaadka leh. Joornaalka Cuntada Nafaqada 2001; 4: 1-6.
  90. Ogata T, Nakamura T Anjitsu K Yaeshima T Takahashi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Iino H. Saamaynta maamulka Bifidobacterium longum BB536 ee ku saabsan deegaanka xiidmaha, saxaarada inta badan iyo astaamaha saxarada ee mutadawiciinta aadanaha. Biosci Microflora 1997; 16: 53-58.
  91. Iwabuchi N, Hiruta N Kanetada S Yaeshima T Iwatsuki K Yasui H. Saamaynta Maamulka Intranasal ee Bifidobacterium longum BB536 oo ku saabsan Nidaamka Difaaca Mucosal ee Cudurka Neefsashada iyo Cudurka Fayraska ee Jiirka. Sayniska Caanka 2009; 38: 129-133.
  92. Sekine I, Yoshiwara S Homma N Takanori H Tonosuka S. Saamaynta caanaha Bifidobacterium ee ku jira falcelinta kiimikada ee leukocytes-ka iyo macnaheedu waa mugga jirka ee unugyada dhiigga cas - doorka suurtogalka ah ee Bifidobacterium ee ku saabsan firfircoonida makrophages. Daaweynta (Japan) 1985; 14: 691-695.
  93. Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi, N., iyo Reddy, BS Bifidobacterium longum, bakteeriyada caloosha ee soosaarta lactic acid waxay xakameysaa kansarka mindhicirka waxayna wax ka bedeshaa biomarkers-ka dhexe ee kansarka mindhicirka weyn. . Kansarka jirka 1997; 18: 833-841. Eeg aragti
  94. Reddy, B. S. iyo Rivenson, A. Saamaynta ka hortagga ee Bifidobacterium longum ee xiidanka, caanaha naaska, iyo kansarka beerka ee ay keento 2-amino-3-methylimidazo [4,5-f] quinoline, oo ah mutagen cunto. Kansarka Res. 9-1-1993; 53: 3914-3918. Eeg aragti
  95. Yamazaki, S., Machii, K., Tsuyuki, S., Momose, H., Kawashima, T., iyo Ueda, K. Jawaabaha Immunological-ka ee isku xidhka dhaadheer ee Bifidobacterium iyo xiriirkooda kahortagga duulaanka bakteeriyada. Immunology 1985; 56: 43-50. Eeg aragti
  96. Kondo, J., Xiao, J. Z., Shirahata, A., Baba, M., Abe, A., Ogawa, K., iyo Shimoda, T. Saamaynta isbadalka ee Bifidobacterium longum BB536 oo ku saabsan saxarada bukaanada waayeelka ah ee qaata quudinta jirka. World J Gastroenterol 4-14-2013; 19: 2162-2170. Eeg aragti
  97. Akatsu, H., Iwabuchi, N., Xiao, JZ, Matsuyama, Z., Kurihara, R., Okuda, K., Yamamoto, T., and Maruyama, M. Dhibaatooyinka Caafimaadka ee Probiotic Bifidobacterium longum BB536 ee Waxqabadka Difaaca iyo Microbiot-ka mindhicirka ee bukaanka waayeelka ah ee qaata Quudinta Tube Isku-dhafan. JPEN J Parenter Enteral Nutr 11-27-2012; Eeg aragti
  98. Odamaki, T., Sugahara, H., Yonezawa, S., Yaeshima, T., Iwatsuki, K., Tanabe, S., Tominaga, T., Togashi, H., Benno, Y., iyo Xiao, JZ Effect qaadashada afka ee caano fadhi ee ay kujirto Bifidobacterium longum BB536 oo kujira nambarada unugyada ee enterotoxigenic Bacteroides fragilis ee microbiota. Anaerobe. 2012; 18: 14-18. Eeg aragti
  99. Iwabuchi, N., Xiao, J. Z., Yaeshima, T., iyo Iwatsuki, K. Maamulka afka ee Bifidobacterium longum wuxuu hagaajiyaa infekshinka fayraska jiirka. Biol.Pharm.Bull. 2011; 34: 1352-1355. Eeg aragti
  100. Simakachorn, N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, JC, Blum, S., Steenhout, P., Benyacoub , J., iyo Schiffrin, Dulqaadka EJ, nabadgelyada, iyo saamaynta ay ku yeelato microbiota faecal-ka ee qaaciidada isku dhafan oo lagu kabayo pre-iyo probiotics ee carruurta aad u jiran. J Pediatr.Gastroenterol.Nutr. 2011; 53: 174-181. Eeg aragti
  101. Hascoet, J. M., Hubert, C., Rochat, F., Legagneur, H., Gaga, S., Emady-Azar, S., iyo Steenhout, P. G. Saamaynta isku dhafka caanaha ee ku saabsan horumarka xiidmaha yar yar ee microbiota. J Pediatr.Gastroenterol.Nutr. 2011; 52: 756-762. Eeg aragti
  102. Firmansyah, A., Dwipoerwantoro, P. G., Kadim, M., Alatas, S., Conus, N., Lestarina, L., Bouisset, F., iyo Steenhout, P. Kobaca sii hagaagaya ee socod baradka wuxuu quudiyay caano ay kujiraan iskudhacyo. Aasiya Pac.J Clin.Nutr. 2011; 20: 69-76. Eeg aragti
  103. Tang, M. L., Lahtinen, S. J., iyo Boyle, R. J. Probiotics iyo prebiotics: saameynta caafimaad ee cudurka xasaasiyadda. Curr.Opin.Pediatr. 2010; 22: 626-634. Eeg aragti
  104. Namba, K., Hatano, M., Yaeshima, T., Takase, M., iyo Suzuki, K. Saamaynta maamulka Bifidobacterium longum BB536 ee ku saabsan infekshinka infalawansada, tallaalka hargabka antibody titer, iyo xasilloonida unugyada ee waayeelka. Biosci.Biotechnol.Biochem. 2010; 74: 939-945. Eeg aragti
  105. Gianotti, L., Morelli, L., Galbiati, F., Rocchetti, S., Coppola, S., Beneduce, A., Gilardini, C., Zonenschain, D., Nespoli, A., iyo Braga, M. Tijaabin laba-indho-indho-indhayn ah oo la kala soocay oo ku saabsan maaraynta daaweynta ee probiotics ee bukaanka kansarka mindhicirka. World J Gastroenterol. 1-14-2010; 16: 167-175. Eeg aragti
  106. Andrade, S. iyo Borges, N. Saamaynta caanaha qallalan oo ay kujiraan Lactobacillus acidophilus iyo Bifidobacterium longum oo kujira baruurta plasma ee dumarka leh kolestarool caadi ah ama dhexdhexaad ah. J.Dairy Res. 2009; 76: 469-474. Eeg aragti
  107. Rouge, C., Piloquet, H., Butel, MJ, Berger, B., Rochat, F., Ferraris, L., Des, Robert C., Legrand, A., de la Cochetiere, MF, N'Guyen, JM, Vodovar, M., Voyer, M., Darmaun, D., iyo Roze, JC Kordhinta afka ah ee loo yaqaan 'probiotics' ee dhallaanka uurka ku jira ee miisaankoodu hooseeyo aad u hooseeya: oo la kala soocay, laba-indhoole ah, tijaabooyin placebo ah. Am.J Clin.Nutr. 2009; 89: 1828-1835. Eeg aragti
  108. Iwabuchi, N., Takahashi, N., Xiao, JZ, Yonezawa, S., Yaeshima, T., Iwatsuki, K., iyo Hachimura, S. Saamaynta cadaadiska ee Bifidobacterium longum ee soosaarka kiimikada loo yaqaan 'Th2-jiidashada' ee loo yaqaan 'T' isdhexgalka unugyada-antigen-soo bandhigida. FEMS Immunol.Med.Microbiol. 2009; 55: 324-334. Eeg aragti
  109. Takeda, Y., Nakase, H., Namba, K., Inoue, S., Ueno, S., Uza, N., iyo Chiba, T. Isuduwaha T-bet iyo mootoolajiyada isgoysyada adag ee loo yaqaan 'Bifidobactrium longum' waxay hagaajineysaa bararka mindhicirka ee calool xanuun. Calool. Calan.Dis. 2009; 15: 1617-1618. Eeg aragti
  110. Soh, SE, Aw, M., Gerez, I., Chong, YS, Rauff, M., Ng, YP, Wong, HB, Pai, N., Lee, BW, iyo Shek, LP Probiotic supplement in the first 6 bilo nololeed oo halis ugu jira dhallaanka Aasiyaanka ah - saamaynta canbaarta iyo xasaasiyadda hidde ah markay jiraan da'da 1 sano. Kliinikada. Xasaasiyadda 2009; 39: 571-578. Eeg aragti
  111. Odamaki, T., Xiao, JZ, Sakamoto, M., Kondo, S., Yaeshima, T., Iwatsuki, K., Togashi, H., Enomoto, T., iyo Benno, Y. Qaybinta noocyada kala duwan ee Bacteroides fragilis koox shaqsiyaadka qaba Japan kedar geed. Appl. Deegaanka.Microbiol. 2008; 74: 6814-6817. Eeg aragti
  112. del Giudice, M. M. iyo Brunese, F. P. Probiotics, prebiotics, iyo xasaasiyadda carruurta: maxaa cusub sanadka soo socda? J Clin Gastroenterol. 2008; 42 Qalabka 3 Pt 2: S205-S208. Eeg aragti
  113. Chouraqui, JP, Grathwohl, D., Labaune, JM, Hascoet, JM, de, Montgolfier, I, Leclaire, M., Giarre, M., iyo Steenhout, P. Qiimaynta amniga, dulqaadka, iyo saamaynta kahortaga shubanka ee qaaciddooyinka dhallaanka ee ay ku jiraan isku-darka probiotics ama probiotics iyo prebiotics ee tijaabada kontoroolka la kala soocay. Am.J Clin.Nutr. 2008; 87: 1365-1373. Eeg aragti
  114. Matsumoto, T., Ishikawa, H., Tateda, K., Yaeshima, T., Ishibashi, N., iyo Yamaguchi, K. Maamulka afka ee Bifidobacterium longum wuxuu ka hortagaa mindhicirka Pseudomonas aeruginosa sepsis ee jiirka. J Appl Microbiol. 2008; 104: 672-680. Eeg aragti
  115. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, T., iyo Benno, Y. Saameynta qaadashada Bifidobacterium longum BB536 ee ku saabsan feecal microbiota shakhsiyaadka qaba cedar pollinosis Japanese inta lagu jiro xilliga manka. J Med.Microbiol. 2007; 56 (Pt 10): 1301-1308. Eeg aragti
  116. Iwabuchi, N., Takahashi, N., Xiao, J. Z., Miyaji, K., iyo Iwatsuki, K. In vitro Th1 cytokine-madaxbannaan Th2 saameynta cadaadiska ee bifidobacteria. Microbiol.Immunol. 2007; 51: 649-660. Eeg aragti
  117. Xiao, JZ, Kondo, S., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., iyo Enomoto, T. Isbedelada heerarka plasma TARC ee xilliga manka iyo xiriirka cilaaqaadka. Int.Arch.Xasaasiyadda Immunol. 2007; 144: 123-127. Eeg aragti
  118. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, T., iyo Benno, Y. Isbeddelka microbiota saxarada ee shakhsiyaadka qaba cedar pollinosis Japanese inta lagu jiro xilliga manka iyo saameynta qaadashada probiotic. J Investig.Allergol.Clin.Immunol. 2007; 17: 92-100. Eeg aragti
  119. Xiao, JZ, Kondo, S., Yanagisawa, N., Miyaji, K., Enomoto, K., Sakoda, T., Iwatsuki, K., iyo Enomoto, T. Waxtarka caafimaad ee probiotic Bifidobacterium longum ee daaweynta astaamaha ee xasaasiyadda manka ee Jabbaan ee maadooyinka lagu qiimeeyay qaybta soo-gaadhista deegaanka. Allergol. 2007; 56: 67-75. Eeg aragti
  120. Puccio, G., Cajozzo, C., Meli, F., Rochat, F., Grathwohl, D., iyo Steenhout, P. Qiimaynta bukaan eegtada ee habka cusub ee bilowga ah ee loogu talagalay dhallaanka ay ku jiraan noolaha Bifidobacterium longum BL999 iyo prebiotics. Nafaqada 2007; 23: 1-8. Eeg aragti
  121. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, K., iyo Enomoto, T. Probiotics-ka ee lagu daweynayo geed-ka-baxa Japan ee loo yaqaan 'cedar pollinosis': laba-indhoole indho-indheyn tijaabo ah. Clin. Ex Xasaasiyadda 2006; 36: 1425-1435. Eeg aragti
  122. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, K., iyo Enomoto, T. Saamaynta probiotic Bifidobacterium longum BB536 [saxay] si loo yareeyo astaamaha caafimaad iyo wax ka beddelka heerarka plasma cytokine ee cedar pollinosis ee Japan inta lagu jiro xilliga manka. Laba-indhoole la kala soocay oo la kala soocay, tijaabo xakamaynta placebo J Investig.Allergol.Clin.Immunol. 2006; 16: 86-93. Eeg aragti
  123. Bennet, R., Nord, C. E., iyo Zetterstrom, R. Gumeysi ku-meelgaar ah oo ku saabsan mindhicirka dhallaanka cusub ee afka lagu maamulo bifidobacteria iyo lactobacilli. Acta Paediatr. 1992; 81: 784-787. Eeg aragti
  124. Zsivkovits, M., Fekadu, K., Sontag, G., Nabinger, U., Huber, WW, Kundi, M., Chakraborty, A., Foissy, H., iyo Knasmuller, S. Ka-hortagga heterocyclic amine-ku-dhalisay Waxyeellada DNA ee xiidanka iyo beerka jiirka ee noocyada lactobacillus kala duwan. Kansarka jirka 2003; 24: 1913-1918. Eeg aragti
  125. Orrhage, K., Sjostedt, S., iyo Nord, C. E. Saamaynta nafaqada ee bakteeriyada lactic acid iyo oligofructose ee microflora xiidmaha inta lagu gudajiro maamulida cefpodoxime proxetil. J Antimicrob Midkale. 2000; 46: 603-612. Eeg aragti
  126. Xiao JZ, Takahashi S, Odamaki T, iyo al. U nuglaanshaha antibiyootikada ee noocyada bifidobacterial ee loogu qaybiyay suuqa Japan.Biosci Biotechnol Biochem. 2010; 74: 336-42. Eeg aragti
  127. AlFaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics ka hortagga necrotizing enterocolitis ee dhallaanka uurka ku jira. Macluumaadka Cochrane ee Dib-u-eegista Nidaamka ah 2011, Issue 3. Art. Maya.: CD005496. DOI: 10.1002 / 14651858.CD005496.pub3. Eeg aragti
  128. Tabbers MM, Milliano I, Roseboom MG, Benninga MA. Miyuu Bifidobacterium breve wax ku ool u yahay daaweynta calool fadhiga carruurnimada? Natiijooyinka daraasad tijaabo ah. Nutr J 2011; 10: 19. Eeg aragti
  129. Leyer GJ, Li S, Mubasher ME, iyo al. Saamaynta probiotic ee hargabka iyo hargabka u eg calaamadaha iyo muddada carruurta. Dhakhaatiirta carruurta 2009; 124: e172-e179. Eeg aragti
  130. Miele E, Pascarella F, Giannetti E. et al. Saameynta aaladda loo yaqaan 'probiotic diyaarinta' (VSL # 3) ee ku saabsan soo-kicinta iyo dayactirka ka-dhaafitaanka carruurta leh ulcerative colitis. Am J Gastroenterol 2009; 104: 437-43. Eeg aragti
  131. Kuhbacher T, Ott SJ, Helwig U, et al. Bakteeriyada iyo fungal microbiota ee la xiriirta daaweynta probiotic (VSL # 3) ee pouchitis. Guut 2006; 55: 833-41. Eeg aragti
  132. Bibiloni R, Fedorak RN, Tannock GW, iyo al. VSL # 3 probiotic-isku-darka ayaa kudhaca cafimaadka bukaanka qaba ulcerative colitis. Am J Gastroenterol 2005; 100: 1539-46. Eeg aragti
  133. Tursi A, Brandimarte G, Giorgetti GM, iyo al. Qiyaasta yar ee balsalazide oo lagu daray diyaargarowga probiotic-ka oo aad u sarreeya ayaa ka waxtar badan tan balsalazide oo keliya ama mesalazine ee daaweynta xanuun ba'an oo dhexdhexaad-ilaa-dhexdhexaad ah. Monit Medit 2004; 10: PI126-31. Eeg aragti
  134. Kato K, Mizuno S, Umesaki Y, iyo al. Tijaabinta xakamaynta xakamaynta xakamaynta ee lagu qiimeeyo saameynta caanaha bifidobacteria-ku-fiiqan ee ku dhaca nabarrada firfircoon. Aliment Pharmacol Ther 2004; 20: 1133-41. Eeg aragti
  135. McFarland LV. Falanqaynta Meta-ka ee probiotics ee loogu talagalay kahortagga shubanka antibiyootikada la xiriira iyo daaweynta cudurka Clostridium wuya. Am J Gastroenterol 2006; 101: 812-22. Eeg aragti
  136. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus iyo bifidobacterium oo ku jira cilladda mindhicirka xanaaqa: jawaabaha astaamaha iyo xiriirka u leh qaababka cytokine. Gastroenterology 2005; 128: 541-51. Eeg aragti
  137. Ishikawa H, Akedo I, Umesaki Y, iyo al. Tijaabinta la xakameeyey ee laxiriira saameynta caanaha bifidobacteria-khamiir ku ah ulcerative colitis. J Am Coll Nutr 2003; 22: 56-63. Eeg aragti
  138. Rastall RA. Bakteeriyada caloosha ku jirta: saaxiibbada iyo cadawga iyo sida loo beddelo dheelitirka. J Nutr 2004; 134: 2022S-2026S. Eeg aragti
  139. Mimura T, Rizzello F, Helwig U, iyo al. Hal mar oo maalinle ah daawo sare oo probiotic ah (VSL # 3) si loo ilaaliyo ka-kabashada soo noq-noqoshada ama diidmada pouchitis-ka. Guut 2004; 53: 108-14. Eeg aragti
  140. Cremonini F, Di Caro S, Covino M, et al. Saameynta diyaargarowga probiotic ee kaladuwan ee daaweynta anti-helicobacter pylori waxyeelada la xiriirta: koox isbarbar socota, indhoolayaal seddexaad ah, daraasad xakamaynta placebo. Am J Gastroenterol 2002; 97: 2744-9. Eeg aragti
  141. Sullivan A, Barkholt L, Nord CE. Lactobacillus acidophilus, Bifidobacterium lactis iyo Lactobacillus F19 waxay ka hortagaan khalkhalka deegaanka ee la xiriira antibiyootikada ee Bakteeriyada jilicsan ee xiidmaha. J Antimicrob Chemother 2003; 52: 308-11. Eeg aragti
  142. Kim HJ, Camilleri M, McKinzie S, iyo al. Maxkamad la kantaroolay oo la kala soocay oo loo yaqaan 'probiotic, VSL # 3, oo ku saabsan marinka xiidmaha iyo astaamaha cudurka shuban-biyoodka caloosha xanaaqa badan. Aliment Pharmacol Ther 2003; 17: 895-904. . Eeg aragti
  143. Roberfroid MB. Daaweynta prebiotics iyo probiotics: waa cunooyin shaqeynaya? Am J Clin Nutr 2000; 71: 1682S-7S. Eeg aragti
  144. Gionchetti P, Rizzello F, Venturi A, iyo al. Daaweynta afka bakteeriyada ee daaweynta dayactirka ee bukaanada qaba pouchitis daba-dheer: laba-indhoole, tijaabinta xakamaynta xakamaynta. Gastroenterology 2000; 119: 305-9. Eeg aragti
  145. Rautio M, Jousimies-Somer H, Kauma H, iyo al. Xanuunka beerka ee loo yaqaan 'Lactobacillus rhamnosus strain' oo aan laga sooci karin L. rhamnosus strain GG. Clin Infect Dis 1999; 28: 1159-60. Eeg aragti
  146. Goldin BR. Faa'iidooyinka Caafimaadka ee daawada probiotics. Br J Nutr 1998; 80: S203-7. Eeg aragti
  147. Kalima P, Masterton RG, Roddie PH, et al. Lactobacillus rhamnosus infekshan ku dhaca cunug ka dib bedelida dhuuxa lafta. J Cudurka 1996; 32: 165-7. Eeg aragti
  148. Saxelin M, Chuang NH, Chassy B, iyo al. Lactobacilli iyo bakteeriya koonfurta Finland 1989-1992. Clin Infect Dis 1996; 22: 564-6. Eeg aragti
  149. Lewis SJ, Freedman AR. Maqaalka dib u eegista: isticmaalka wakiilada biotherapeutic ee ka hortagga iyo daaweynta cudurka caloosha iyo mindhicirka. Aliment Pharmacol Ther 1998; 12: 807-22. Eeg aragti
  150. Meydani SN, Ha WK. Saamaynta tallaalka yogurt. Am J Clin Nutr 2000; 71: 861-72. Eeg aragti
  151. Isolauri E, Arvola T, Sutas Y, iyo al. Probiotics-ka ee maamulka cambaarta hidde ah. Clin Xasaasiyadda 2000; 30: 1604-10. Eeg aragti
  152. Korschunov VM, Smeyanov VV, Efimov BA, iyo al. Isticmaalka daweynta ee u diyaargarowga antibiyootikada ee loo yaqaan 'Bifidobacterium' ee ragga loogu talagalay qiyaasta sare ee gamma-irradiation. J Med Microbiol 1996; 44: 70-4. Eeg aragti
  153. Venturi A, Gionchetti P, Rizzello F, iyo al. Saameyn ku yeelashada halabuurka faecal flora ee diyaarinta probiotic cusub: xog hordhac ah oo ku saabsan daaweynta dayactirka bukaanka qaba ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1103-8. Eeg aragti
  154. Phuapradit P, Varavithya W, Vathanophas K, iyo al. Yaraynta infekshanka rotafayruusta ee carruurta qaata caano bifidobacteria lagu daro. J Med Assoc Thai 1999; 82: S43-8. Eeg aragti
  155. Hoyos AB. Hoosudhaca dhacdooyinka necrotizing enterocolitis ee laxiriira maamulka gudaha ee Lactobacillus acidophilus iyo Bifidobacterium infantis oo loogu tala galay dhallaanka qeybta daryeelka degdegga ah. Int J Infect Dis 1999; 3: 197-202. Eeg aragti
  156. Pierce A. Ururka Dawooyinka ee Mareykanka Tilmaamaha Waxqabadka ee Daawooyinka Dabiiciga ah. New York: Stonesong Press, 1999: 19.
  157. Chen RM, Wu JJ, Lee SC, iyo al. Kordhinta Bifidobacterium xiidmaha iyo xakamaynta bakteeriyada coliform oo leh caano fadhi muddo gaaban ah. J Caanaha Sci 1999: 82: 2308-14. Eeg aragti
  158. Ha GY, Yang CH, Kim H, Chong Y. Xaaladda sepsis ee uu sababo Bifidobacterium longum. J Clin Microbiol 1999; 37: 1227-8. Eeg aragti
  159. Colombel JF, Cortot A, Neut C, Romond C. Yoghurt oo leh Bifidobacterium longum wuxuu yareynayaa saamaynta caloosha ee erythromycin. Lancet 1987; 2: 43.
  160. Hirayama K, Rafter J. Doorka bakteeriyada probiotic ee ka hortagga kansarka. Cudurka Microbes 2000; 2: 681-6. Eeg aragti
  161. Macfarlane GT, Cummings JH. Probiotics iyo prebiotics: ma xakamayn kartaa waxqabadka bakteeriyada mindhicirka waxtar ayey u leedahay caafimaadka? BMJ 1999; 318: 999-1003. Eeg aragti
  162. Chiang BL, Sheih YH, Wang LH, iyo al. Kordhinta difaaca jirka ee cunnooyinka bakteeriyada loo yaqaan 'probiotic lactic acid bacterium' (Bifidobacterium lactis HN019): fiicnaanta iyo qeexida jawaabaha difaaca jirka. Eur J Clin Nutr 2000; 54: 849-55. Eeg aragti
  163. Lievin V, Peiffer I, Hudault S, iyo al. Noocyada 'Bifidobacterium' ee ka imanaya ilmaha yar ee deggan microflora caloosha ku jira ayaa sameeya waxqabadka antimicrobial. Guut 2000; 47: 646-52. Eeg aragti
  164. Arunachalam K, Gill HS, Chandra RK. Kordhinta shaqada difaaca jirka ee dabiiciga ah ee cunnada loo isticmaalo Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000; 54: 263-7. Eeg aragti
  165. Bouhnik Y, Pochart P, Marteau P, et al. Soo kabashada saxarada bini-aadamka ee wax ku oolka ah ee loo yaqaan 'bifidobacterium' ee lagu liqay caano qallalan. Gastroenterology 1992; 102: 875-8. Eeg aragti
  166. Saavedra JM, et al. Quudinta bifidobacterium bifidum iyo streptococcus thermophilus dhallaanka ku jira isbitaalka si looga hortago shubanka iyo daadinta rotavirus. Lancet 1994; 344: 1046-9. Eeg aragti
  167. Scarpignato C, Rampal P. Ka-hortagga iyo daaweynta shuban-biyoodka socdaalka: Habka dawooyinka daaweynta. Chemotherapy 1995; 41: 48-81. Eeg aragti
  168. Elmer GW, Surawicz CM, McFarland LV. Wakiilada Biotherapeutic, Habka dayacan ee daaweynta iyo ka hortagga cudurada xiidmaha iyo xubinta taranka ee la xushay. JAMA 1996; 275: 870-5. Eeg aragti
Markii ugu dambeysay ee dib loo eegay - 11/25/2020

Xiriirinta Daabacashada

Nabdoonaanta galmada dabada: Wax kasta oo aad ubaahantahay inaad ogaato
Caafimaadka

Nabdoonaanta galmada dabada: Wax kasta oo aad ubaahantahay inaad ogaato

Waxaan ku darnaa badeecooyin aan u maleyneyno inay faa'iido u leeyihiin akhri tayaa hayada. Haddii aad wax kaga iib ato xiriiriyeyaa ha ku yaal boggan, waxaa laga yaabaa inaan ka bano komi han yar...
Goobo bunni ah oo ku yaal Ilkaha
Caafimaadka

Goobo bunni ah oo ku yaal Ilkaha

Daryeelka ciridkaaga iyo ilkahaaga waxay kaa caawiney aa inaad ka fogaato ilkaha uu iyo neefta xun. Waxay kaloo kaa caawiney aa inaad i ka ilaali o cudurka ciridka. Qeyb muhiim ah oo ka mid ah nadaafa...